GLP-1 use and breast cancer risk | Using mammo to assess cardiovascular risk | AI discerns need for supplemental imaging | More

The study, which was managed by the American College of Radiology, is raising important questions related to the benefits of GLP-1 use.

Experts say these findings could offer radiology providers the opportunity to intervene before cardiovascular conditions worsen.

AI shines as a first reader for ruling out suspicious findings in breast cancer screening exams, a new analysis in Radiology: Artificial Intelligence reveals.

Researchers are hopeful that the patch can give providers the data needed to identify critical abnormalities earlier. 

The needles were added to the FDA’s list of device shortages in April months after a major manufacturer stopped shipments to “correct an issue."

And the uptick in incidence rates is not exclusive to any one demographic or tumor subtype, experts caution.

New findings support the routine use of deep learning-based risk assessments, as this method can decrease subjectivity, reduce unnecessary imaging and improve diagnostic accuracy. 

The 4D system harnesses X-ray diffraction to measure molecular-level signatures of disease; these tissue “fingerprints” could help providers diagnose breast cancer in its earliest stages.

It may be more than anxiety and forgetfulness to blame for women missing their scheduled mammograms, according to new survey data. 

New findings suggest that 99mTc-maraciclatide can help physicians more accurately identify endometriosis on imaging.